Somatic NF1 mutations in tumors and other tissues

Monographs in Human Genetics

Volumn 16, Issue , 2008, Pages 143-153

  Raedt, T D ^a   Maertens, O ^b   Serra, E ^c   Legius, E ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650448215     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000126580     Document Type: Article

References (80)

1. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, et al: Guidelines for the diagnosis and management of individuals with Neurofibromatosis 1 (NF1). J Med Genet 2007;44:81-88.
2. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J: Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 1988;59:760-771. (Pubitemid 19019457)
3. Rosenbaum TP, Patrie KM, Ratner N: Neurofibromatosis Type 1: Genetic and cellular mechanisms of peripheral nerve tumor formation. The Neuroscientist 1997;3:412-420.
4. Kluwe L, Friedrich R, Mautner VF: Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. Genes Chromosomes Cancer 1999;24:283-285. (Pubitemid 29070169)
5. Rutkowski JL, Wu K, Gutmann DH, Boyer PJ, Legius E: Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet 2000;9:1059-1066. (Pubitemid 30216011)
6. Serra E, Rosenbaum T, Winner U, Aledo R, Ars E, et al: Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum Mol Genet 2000;9:3055-3064. (Pubitemid 32000779)
7. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
8. Maertens O, Brems H, Van De Sompele J, De Raedt T, Heyns I, et al: Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mut 2006;27:1030-1040. (Pubitemid 44454056)
9. Horan MP, Cooper DN, Upadhyaya M: Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours. Hum Genet 2000;107:33-39. (Pubitemid 30598944)
10. Harder A, Rosche M, Reuss DE, Holtkamp N, Uhlmann K, et al: Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Eur J Cancer 2004;40:2820-2828. (Pubitemid 39574737)
11. Luijten M, Redeker S, Van Noesel MM, Troost D, Westerveld A, Hulsebos TJ: Microsatellite instability and promoter methylation as possible causes of NF1 gene inactivation in neurofibromas. Eur J Hum Genet 2000;8:939-945. (Pubitemid 32094345)
12. Fishbein L, Eady B, Sanek N, Muir D, Wallace MR: Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells. Cancer Genet Cytogenet 2005;157:181-186. (Pubitemid 40255202)
13. Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, et al: Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors. Hum Mutat 2004;23:134-146. (Pubitemid 38200604)
14. De Raedt T, Maertens O, Chmara M, Brems H, Heyns I, et al: Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosomes Cancer 2006;45:893-904. (Pubitemid 44360177)
15. Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lazaro C: Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 2001;28:294-296. (Pubitemid 32626036)
16. Wiest V, Eisenbarth I, Schmegner C, Krone W, Assum G: Somatic NF1 mutation spectra in a family with neurofibromatosis type 1: toward a theory of genetic modifiers. Hum Mutat 2003;22:423-427. (Pubitemid 38009944)
17. Serra E, Puig S, Otero D, Gaona A, Kruyer H, et al: Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 1997;61:512-519. (Pubitemid 27418392)
18. Serra E, Ars E, Ravella A, Sanchez A, Puig S, et al: Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum Genet 2001;108:416-429. (Pubitemid 32492448)
19. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D: Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996;14:110-112. (Pubitemid 26301558)
20. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, et al: Chromosome 17 lossofheterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 2000;28:425-431. (Pubitemid 30451795)
21. Lothe RA, Slettan A, Saeter G, Brogger A, Borresen AL, Nesland JM: Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 1995;54:65-73.
22. Eisenbarth I, Beyer K, Krone W, Assum G: Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet 2000;66:393-401. (Pubitemid 30468816)
23. Daschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, et al: Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun 1997;234:346-350. (Pubitemid 27243905)
24. Colman SD, Williams CA, Wallace MR: Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995;11:90-92.
25. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-314. (Pubitemid 34526349)
26. Legius E, Marchuk DA, Collins FS, Glover TW: Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993;3:122-126. (Pubitemid 23079793)
27. Lothe RA, Slettan A, Saeter G, Brogger A, Borresen AL, Nesland JM: Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 1995;54:65-73.
28. Lothe RA, Saeter G, Danielsen HE, Stenwig AE, Hoyheim B, O'Connell P, Borresen AL: Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1). Pathol Res Pract 1993;189:465-471; discussion 464-471.
29. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN: Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 1999;155:1879-1884.
30. Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM: Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 1999;155:1855-1860.
31. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, et al: Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 1990;87:5435-5439.
32. Legius E, Dierick H, Wu R, Hall BK, Marynen P, Cassiman JJ, Glover TW: TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 1994;10:250-255. (Pubitemid 24238432)
33. Mertens F, Dal Cin P, De Wever I, Fletcher CD, Mandahl N, et al: Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 2000;190:31-38. (Pubitemid 30053350)
34. Zoller ME, Rembeck B, Oden A, Samuelsson M, Angervall L: Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997;79:2125-2131. (Pubitemid 27227376)
35. Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, et al: Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006;15:1015-1023. (Pubitemid 43338241)
36. Stewart DR, Corless CL, Rubin BP, Heinrich MC, Messiaen LM, et al: Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. Journal of medical genetics 2007;44:e61.
37. Stewart W, Traynor JP, Cooke A, Griffiths S, Onen NF, et al: Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene. Fam Cancer 2007;6:147-152. (Pubitemid 46295294)
38. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. Br J Cancer 1994;70:969-972. (Pubitemid 24331097)
39. Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers EL, et al: Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood 1996;88:4314-4320. (Pubitemid 26399179)
40. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:597-601. (Pubitemid 24065793)
41. Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM: Shannon KM: Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood 2006;108:1684-1689. (Pubitemid 44316138)
42. Listernick R, Charrow J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125:63-66. (Pubitemid 24225179)
43. Gutmann DH, Donahoe J, Brown T, James CD, Perry A: Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 2000;26:361-367. (Pubitemid 30609432)
44. Gutmann DH, James CD, Poyhonen M, Louis DN, Ferner R, et al: Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1. Neurology 2003;61:1397-1400. (Pubitemid 37463377)
45. Li J, Perry A, James CD, Gutmann DH: Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001;56:885-890. (Pubitemid 32290805)
46. Kluwe L, Hagel C, Tatagiba M, Thomas S, Stavrou D, et al: Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001;60:917-920. (Pubitemid 32880599)
47. Tada K, Kochi M, Saya H, Kuratsu J, Shiraishi S, et al: Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1. Neuro Oncol 2003;5:228-234. (Pubitemid 37265902)
48. Lenders JW, Eisenhofer G, Mannelli M, Pacak K: Phaeochromocytoma. Lancet 2005;366:665-675. (Pubitemid 41176020)
49. Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT: Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1983;58:802-804. (Pubitemid 14205531)
50. Stenstrom G, Svardsudd K: Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand 1986;220:225-232. (Pubitemid 17168529)
51. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627.
52. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM: von Recklinghausen's disease and pheochromocytomas. J Urol 1999;162:1582-1586. (Pubitemid 29474665)
53. Gutmann DH, Cole JL, Stone WJ, Ponder BA, Collins FS: Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I. Genes Chromosomes Cancer 1994;10:55-58. (Pubitemid 24137269)
54. Hering A, Guratowska M, Bucsky P, Claussen U, Decker J, et al: Loncarevic I: Characteristic genomic imbalances in pediatric pheochromocytoma. Genes Chromosomes Cancer 2006;45:602-607. (Pubitemid 43727167)
55. Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CG, Ponder BA: Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 1992;4:337-342.
56. Friedman JM, Birch PH: Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1, 728 patients. Am J Med Genet 1997;70:138-143. (Pubitemid 27184570)
57. Huson SM, Harper PS, Compston DA: Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111:1355-1381. (Pubitemid 19028458)
58. Korf BR: Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics 1992;90:924-927.
59. Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, et al: Carey JC: Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet 1999;84:413-419. (Pubitemid 29239282)
60. Riccardi VM: Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore and London: The John Hopkins University Press; 1992.
61. Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, et al: Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 2006;79:143-148. (Pubitemid 43927385)
62. De Schepper S, Boucneau J, Van der Haeghen Y, Messiaen L, Naeyaert JM, Lambert J: Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind? Arch Dermatol Res 2006;297:439-449.
63. Kaufmann D, Wiandt S, Veser J, Krone W: Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF1). Hum Genet 1991;871:144-150.
64. De Schepper S, Maertens O, Callens T, Naeyaert J-M, Lambert J, Messiaen L: Somatic mutation analysis in NF1 café-au-lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol 2008;128:1050-1053. (Pubitemid 351374293)
65. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R, Somers R, Messiaen L, De Schepper S, Fryns JP, Cools J, Marynen P, Thomas G, Yoshimura A, Legius E: Germline loss-offunction mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007;39:1120-1126. (Pubitemid 47340658)
66. Ainsworth PJ, Chakraborty PK, Weksberg R: Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion. Hum Mutat 1997;9:452-457. (Pubitemid 27194900)
67. Colman SD, Rasmussen SA, Ho VT, Abernathy CR, Wallace MR: Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet 1996;58:484-490. (Pubitemid 26062479)
68. Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, et al: High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 2004;75:410-423. (Pubitemid 39095817)
69. Petek E, Jenne DE, Smolle J, Binder B, Lasinger W, et al: Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. J Med Genet 2003;40:520-525. (Pubitemid 36843075)
70. Rasmussen SA, Colman SD, Ho VT, Abernathy CR, Arn PH, et al: Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 1998;35:468-471. (Pubitemid 28252154)
71. Riva P, Corrado L, Natacci F, Castorina P, Wu BL, et al: NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes. Am J Hum Genet 2000;66:100-109. (Pubitemid 30481472)
72. Streubel B, Latta E, Kehrer-Sawatzki H, Hoffmann GF, Fonatsch C, Rehder H: Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2. Am J Med Genet 1999;87:12-16. (Pubitemid 29522055)
73. Tonsgard JH, Yelavarthi KK, Cushner S, Short MP, Lindgren V: Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 1997;73:80-86. (Pubitemid 27467532)
74. Wu BL, Boles RG, Yaari H, Weremowicz S, Schneider GH, Korf BR: Somatic mosaicism for deletion of the entire NF1 gene identified by FISH. Hum Genet 1997;99:209-213. (Pubitemid 27073324)
75. Maertens O, De Schepper S, Van De Sompele J, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L: Molecular dissection of isolated disease features in neurofibromatosis type 1. Am J Hum Genet 2007;81:243-251. (Pubitemid 47236073)
76. Tinschert S, Naumann I, Stegmann E, Buske A, Kaufmann D, Thiel G, Jenne DE: Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 2000;8:455-459. (Pubitemid 30364826)
77. Van Den Broucke I, Van Doorn R, Callens T, Cobben JM, Starink TM, Messiaen L: Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 2004;114:284-290. (Pubitemid 38208307)
78. Consoli C, Moss C, Green S, Balderson D, Cooper DN, Upadhyaya M: Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J Invest Dermatol 2005;125:463-466.
79. Lazaro C, Gaona A, Lynch M, Kruyer H, Ravella A, Estivill X: Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ line mosaicism. Am J Hum Genet 1995;57:1044-1049.
80. Maertens O, Speleman F, Legius E, Messiaen L: The somatic NF1 mutation database. (submitted)